Forte Biosciences, Inc. Common Stock (FBRX) Stock Price

FBRXStock

$76.97+573.23%52W

Market Cap$1.63B

P/E—

PEG Ratio—

Div yield—

Beta2.30

FBRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)152.01%

Price vs S&P 500 (4W)-2.66%

VGM Score37.43

Book Value / Share (Quarterly)$3.03

P/TBV (Annual)0.42x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-7.17%

Cash Flow / Share (Quarterly)$-4.27

Price vs S&P 500 (YTD)170.22%

Net Profit Margin (TTM)-158775.00%

EPS (TTM)$-4.58

10-Day Avg Trading Volume1.89M

EPS Excl Extra (TTM)$-4.58

Revenue Growth (5Y)-7.79%

EPS (Annual)$-4.71

ROI (Annual)-113.75%

Net Profit Margin (5Y Avg)-73895.28%

Cash / Share (Quarterly)$4.19

Revenue Growth QoQ (YoY)0.00%

ROA (Last FY)-83.81%

Revenue Growth TTM (YoY)-99.78%

EBITD / Share (TTM)$-4.72

ROE (5Y Avg)-71.71%

Operating Margin (TTM)-150175.00%

Cash Flow / Share (Annual)$-3.94

P/B Ratio37.41x

P/B Ratio (Quarterly)8.54x

Net Income / Employee (Annual)$-3,651,300

EV / Revenue (TTM)37913.38x

Net Interest Coverage (TTM)-27.11x

ROA (TTM)-85.50%

EPS Incl Extra (Annual)$-4.71

Current Ratio (Annual)3.88x

Quick Ratio (Quarterly)2.50x

3-Month Avg Trading Volume0.99M

52-Week Price Return573.23%

Revenue / Employee (TTM)$2,100

Tangible BV / Share (Quarterly)$1.11

P/S Ratio (Annual)39368.96x

Asset Turnover (Annual)0.00x

52-Week High$77.20

Operating Margin (5Y Avg)-70736.83%

EPS Excl Extra (Annual)$-4.71

CapEx CAGR (5Y)-38.77%

Tangible BV CAGR (5Y)-11.40%

26-Week Price Return163.26%

Quick Ratio (Annual)3.77x

13-Week Price Return249.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.75x

Enterprise Value$1.52B

Revenue / Share Growth (5Y)-12.31%

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)0.47%

Revenue / Employee (Annual)$2,100

Pretax Margin (Annual)-158800.00%

Cash / Share (Annual)$5.94

3-Month Return Std Dev185.55%

Net Income / Employee (TTM)$-3,992,400

ROE (Last FY)-113.75%

Net Interest Coverage (Annual)-27.23x

EPS Basic Excl Extra (Annual)$-4.71

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-4.58

ROI (TTM)-106.16%

P/S Ratio (TTM)39368.96x

Pretax Margin (5Y Avg)-73893.39%

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$1.85

Price vs S&P 500 (52W)554.92%

Year-to-Date Return182.18%

5-Day Price Return0.09%

EPS Normalized (Annual)$-4.71

ROA (5Y Avg)-61.08%

Net Profit Margin (Annual)-158800.00%

Month-to-Date Return0.46%

Cash Flow / Share (TTM)$-0.86

EBITD / Share (Annual)$-4.80

Operating Margin (Annual)-150175.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-71.71%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-4.58

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)5.60x

Pretax Margin (TTM)-158775.00%

Book Value / Share (Annual)$4.71

Price vs S&P 500 (13W)246.98%

Beta2.30x

Revenue / Share (TTM)$0.03

ROE (TTM)-106.16%

52-Week Low$10.11

vGradeF

gGradeF

mGradeA

vgmGradeD

FBRX Earnings Surprise History

Q2 25-0.96est. -1.11

Q3 25-0.99est. -1.07

Q4 25-1.45est. -1.15

Q1 26-1.24est. -1.16

Q2 26-0.97est. -0.88

FBRX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.17

4.18

3.73

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
FBRXForte Biosciences, Inc. Common Stock	F	F	A	$76.97
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Forte Biosciences, Inc. Common Stock

Forte Biosciences is a biopharmaceutical company developing FB-102, a proprietary therapeutic molecule targeting autoimmune and inflammatory disorders. The candidate is in preclinical trials with potential applications in graft-versus-host disease, vitiligo, alopecia areata, and type 1 diabetes.